For employers, keeping members engaged with their health care is one of the key factors that leads to better outcomes, said Jeremy Wigginton, MD, vice president of health quality and innovation at Blue Cross and Blue Shield of Louisiana.
In the first part of this interview, Jeremy Wigginton, MD, vice president of health quality and innovation at Blue Cross and Blue Shield of Louisiana, said telehealth and other forms of remote patient monitoring help "bridge the gap between visits" and provide continued support for patients. Here, Wigginton expands on that comment, adding what he hears from employers about their interest and responsibilities in improving patient outcomes.
Transcript
Speaking to your idea that health care doesn't only happen in the doctor's office, what are employers telling you about their interest in diabetes outcomes?
Employers, like I said, have a very unique position in that they have the ability to really engage their population, their employees. So, you're absolutely right that health care happens all the time. People with diabetes have diabetes 24 hours a day; they don't just have diabetes when they go to the doctor's office. So there can be lots of things that can, like I said, help augment their relationship with their primary care physician or the provider that is helping to treat their diabetes.
When we work with employers, we really look at the data around their population because, as the largest commercial insurer in the state of Louisiana, we have access to a lot of data. For employee populations, particularly, we can really look at the health of that population. We can see who's at risk for diabetes. Those that have diabetes, how well are they taking care of their diabetes? Are they getting good A1C control? Do they also have hypertension? Are they having any other issues like kidney disease? It's really about engaging those employees to stay involved in their health care, not just telling them to go to the doctor once a year or once every 6 months. It's really about keeping them engaged every day, watching their diet, keeping them with very good access to resources—both around education and support for their conditions.
So, you're absolutely right that employers really want to see those better outcomes, because better outcomes lead to very high value, which really is about the same for members and employers. They want to see really great outcomes that is at an affordable cost. They want to really feel that they're getting something for their health care dollar.
Employers can really partner very closely with those employees to give them really great visibility into their health insurance benefits, to educate them if they have access to particular programs or technologies. They really have an important place in our health care system to help keep their members engaged. Engagement is really one of the key factors that leads to better outcomes, so that's really an important piece.
Real-World Data Show Sotorasib Effective for NSCLC With KRAS Mutation
May 18th 2024Data from real-world and clinical-trial settings on frontline monotherapy treatment with the KRAS inhibitor sotorasib both show similar progression-free survivals and a high likelihood that the treatment’s efficacy is not affected with dose reduction.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Health Equity and Access Weekly Roundup: May 18, 2024
May 18th 2024The US Senate hosted a panel addressing physician and health care shortages and efforts to increase minority representation in the medical field. An expert discussed initiatives to prevent senior homelessness. Advocates called for the repeal of the Comstock Act. Regulatory reforms are called for to improve rural cancer patients' access to pharmacies. Research reveals the impact of denials on patient access to immunology treatments.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More